Business
Celldex to Present at Upcoming Investor Conferences
HAMPTON, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in fireside chats at the following
About this update from Celldex Therapeutics, Inc.
HAMPTON, N.J. , Nov. 07, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in fireside chats at the following upcoming investor conferences: Guggenheim 2nd Annual Healthcare Innovation Conference on Tuesday, November 11 at 10:00 am ET TD Cowen Immunology & Inflammation Summit on Thursday, November 13 at 9:30 am ET 8th Annual Evercore Healthcare Conference on Tuesday, December 2 at 3:00 pm ET Live webcasts of the presentations will be available on the " Events & Presentations " page of the "Investors" section of the Celldex website. Replays will be available for 90 days following the event. About Celldex Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders.Visit www.celldex.com . Company Contact Sarah Cavanaugh Senior Vice President, Corporate Affairs & Administration(508) 864-8337 [email protected] Patrick Till Meru Advisors (484) 788-8560 [email protected] Source: Celldex Therapeutics, Inc.
View stock analysis, news, and events for Celldex Therapeutics, Inc.